+1 (888) 794-0077
« Return

Virtual Tours Available Today

Explore our New Jersey facilities from wherever you are working, even the comfort of your own home.

Virtually tour our New Jersey facilities in Cranbury and Plainsboro to learn about our Bioanalytical and DMPK capabilities and instrumentation to support your drug discovery and development programs.

Let’s discuss how we can help you meet your goals!

Follow WuXi AppTec Laboratory Testing Division on LinkedIn for industry insights and program support.

For more information, please visit: https://labtesting.wuxiapptec.com/


As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the global pharmaceutical and life sciences industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received an AA ESG rating from MSCI for the fourth consecutive year in 2024 and its open-access platform is enabling around 6,000 customers from over 30 countries to improve the health of those in need – and to realize the vision that “every drug can be made and every disease can be treated.”

Related Posts

Key Challenges in Oligonucleotide Bioanalysis—And How to Overcome Them

Key Challenges in Oligonucleotide Bioanalysis—And How to Overcome Them

Oligonucleotide therapeutics (oligos) have emerged as a groundbreaking class of drugs with the potential to treat previously untreatable diseases. By targeting RNA or modulating protein function, therapies such as antisense oligonucleotides (ASOs), small interfering RNA (siRNA), and aptamers offer new avenues for precision medicine. However, their development is not without hurdles, particularly in bioanalysis. Their unique properties demand advanced analytical methods to ensure accuracy, stability, and regulatory compliance.

What Is Large Molecule Preclinical Testing? Overview, Objectives, and Key Test Methods

What Is Large Molecule Preclinical Testing? Overview, Objectives, and Key Test Methods

Large molecule drug candidates face unique challenges in preclinical testing due to their complexity, but with the right strategies, researchers can navigate these hurdles and develop novel therapeutics. This comprehensive guide walks you through everything you need to know about large molecule preclinical testing, ensuring potential risks are minimized and the drug’s full potential is realized.